|
| Issue Date | Title | Author(s) |
| 15-Nov-2019 | 1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC | Dokla, Eman ; Fang, Chun Sheng; Chen, Ching S.; Abouzid, Khaled |
| 1-Jul-2018 | A 5′ AMP-Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral Squamous Cell Carcinoma | Weng, Jing Ru; Dokla, Eman ; Bai, Li Yuan; Chen, Ching Shih; Chiu, Shih Jiuan; Shieh, Tzong Ming |
| 2023 | AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase | Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah |
| 2025 | Anticancer activity of EMD37 against human head and neck cancer: Impact on apoptotic and inflammatory machineries | Marwa Sharaky; Amal Kamal Abdel-Aziz; Dokla, Eman |
| 27-Nov-2012 | Applying Ligands Profiling Using Multiple Extended Electron Distribution Based Field Templates and Feature Trees Similarity Searching in the Discovery of New Generation of Urea-Based Antineoplastic Kinase Inhibitors | Dokla, Eman ; Mahmoud, Amr H.; Elsayed, Mohamed S.A.; El-Khatib, Ahmed H.; Linscheid, Michael W.; Khaled A M Abouzid |
| 15-Jan-2020 | Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria | Abutaleb, Nader S; Milik, Sandra N; Li, Daoyi; El-Baz, Karim; Shalaby, Menna-Allah W; Al-Karaki, Rawan; Nasr, Maha ; Klein, Christian D; Seleem, Mohamed N; Dokla, Eman ; Khaled A M Abouzid |
| Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| 15-Feb-2022 | Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| Dec-2022 | Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity | Abdel-Aziz, Amal Kamal ; Khaled A M Abouzid ; Minucci, Saverio; Dokla, Eman |
| Nov-2023 | FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review | Abdel-Aziz, Amal Kamal ; Saadeldin, Mona Kamal; Dokla, Eman |
| 2024 | FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives | Heba M. Hesham; Eman Z. Elrazaz; Deena S. Lasheen; Dalal A. Abou El Ella; Dokla, Eman |
| 2019 | Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation | Shalaby, Menna-Allah; Dokla, Eman ; Serya, Rabah ; Abouzid, Khaled |
| 1-Dec-2021 | Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; Mahmoud, Amr H.; Saadeldin, Mona Kamal; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 1-Jun-2022 | Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells | Chu, Po Chen; Dokla, Eman ; Hu, Jing Lan; Weng, Jing Ru |
| 1-Dec-2013 | Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3- & 4-[3-(3,5-dibromo-4-hydroxyphenyl)-propylamino] phenyl) butyric acids and 3-(3,5-dibromo-4-hydroxyphenyl)-propylamino- acetamidobenzoic acid esters | Ismail, Mohamed Abdel Hamid; Mohamed, Nasser Saad; Dokla, Eman ; Khaled A M Abouzid |
| 2023 | Nanoemulgel formulation of a benzimidazole derivative for wound healing | Riham I. El-Gogary; Nada M. Abd-Elsaid; Mariam Gad; Reem K. Abd-Elhalim; Hana H. Habib; Wesam Eldeeb; Esraa R. Eldahshan; Salma H. Nassar; Aya N. Issa; Neveen Rabeh; Samar Abd-Elkhalik; Maha Nasr; Dokla, Eman |
| 15-Mar-2024 | Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells | Abdel-Aziz, Amal Kamal ; Ahmed, Tarek E.; Hatem, Yasmin; Abdel Rahman, Engy A.; Sharaky, Marwa; Shahin, Mai I. ; Elrazaz, Eman Z.; Serya, Rabah A.T. ; Henary, Maged; Ali, Sameh S.; Abou El Ella, Dalal A.; Dokla, Eman ; Helmy, Sama |
| 1-Aug-2020 | Penicillin binding protein 2a: An overview and a medicinal chemistry perspective | Shalaby, Menna-Allah W; Dokla, Eman ; Serya, Rabah ; Khaled A M Abouzid |
| 22-Dec-2022 | SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria | Dokla, Eman ; Abutaleb, Nader S; Milik, Sandra N; Kandil, Ezzat A E A; Qassem, Omar M; Elgammal, Yehia; Nasr, Maha ; McPhillie, Martin J; Abouzid, Khaled A M; Seleem, Mohamed N; Imming, Peter; Adel, Mai |
| May-2025 | Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML | El-Deen, Nada Alaa; DeFilippis, RosaAnna; Milik, Sandra N; Patel, Suhana; Ismail, Muhammad I; Khaled, Omar; Ahmed, Tarek Erfan; Abdelfattah, Ayatullah Gamal; Ali, Eslam M H; Gaballah, Maiy Y; McPhillie, Martin J; Abouzid, Khaled A M; Henary, Maged; Minucci, Saverio; Shah, Neil P; Abdel-Aziz, Amal Kamal ; Serya, Rabah ; Dokla, Eman |
